Background. Reactivation of human herpesvirus 6 (HHV-6) appears to be common after
transplant. Viral reactivation may result in febrile illness and may also play an …

Background Reactivation of human herpesvirus (HHV)-6 and HHV-7 has been linked to
various posttransplant adverse events through immunomodulatory effects. The potential …

To analyze human herpesvirus 6 (HHV‐6) infection in adult living related liver
transplantation, we performed a virological analysis, including viral isolation, serological …

Human herpesvirus 8 (HHV8) is pathogenic in humans, especially in cases of
immunosuppression. We evaluated the risk of HHV8 transmission from liver donors, and its …

Abstract Human herpesvirus 6 (HHV‐6A and HHV‐6B) can cause primary infection or
reactivate from latency in liver transplant recipients, which can result in a variety of clinical …

Abstract Human herpesvirus 6 (HHV-6) infection is potentially life-threatening to
immunosuppressed patients. There is a lack of information regarding the risk and the clinical …

Abstract Human herpes virus 6 (HHV-6) infects> 95% of humans. Primary infection which
occurs mostly during the first 2 years of life in the form of roseola infantum, non-specific …

A diagnosis of posttransplantation human herpesvirus-6 (HHV-6) infection was established
for eight adult recipients among a liver transplantation patient population of 121. The …

Background. Theclinical impact and relevance of human herpesvirus-6 (HHV-6) infection in
liver transplant recipients, has not been fully discerned. Methods. A prospective study of 80 …

Abstract Human herpesvirus 6 (HHV-6) infections occur in> 95% of humans. Primary
infection, which occurs in early childhood as an asymptomatic illness or manifested clinically …